Buspirone
بوسپیرون
🧠 Nervous SystemNon-benzodiazepine anxiolytic
Market / country: 🇺🇸 USA
Buspar (US)
🧮 Dose calculator
Anxiety and tension · Regimen source: FDA Buspirone · Dosage and Administration
- • Increase 5 mg/day every 2–3 days; usually 20–30 mg/day. FDA Buspirone · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity; MAOI within 14 days. FDA Buspirone · Contraindications
Formulations
- 15 mg tablet (scored) — tablet 🇺🇸 USA FDA Buspirone · Patient instructions — breaking the 15 mg tablet
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Buspirone · Precautions/Warnings – Pregnancy
“Teratogenic Effects Pregnancy Category B: No fertility impairment or fetal damage was observed in reproduction studies performed in rats and rabbits at buspirone doses of approximately 30 times the maximum recommended human dose.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Buspirone · Nursing Mothers
“The extent of the excretion in human milk of buspirone or its metabolites is not known.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Buspirone · Pediatric Use
“The safety and effectiveness of buspirone were evaluated in two placebo-controlled 6-week trials involving a total of 559 pediatric patients (ranging from 6 to 17 years of age) with GAD.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Buspirone · Precautions/Warnings – Geriatric Use
“In one study of 6632 patients who received buspirone for the treatment of anxiety, 605 patients were ≥65 years old and 41 were ≥75 years old; the safety and efficacy profiles for these 605 elderly patients (mean age = 70.8 years) were similar to those in the younger population (mean age = 43.3 years).”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA202087
- DailyMed (FDA label)FDA Buspirone
- MedlinePlus (NIH)Buspirone
- WHO ATC/DDDN05BE01
- Darooyab (Iran)Buspirone
🇮🇷 Registered in Iran Darooyab · G-1238/Buspirone
Dosage forms with Iranian generic codes, per Darooyab.
- 11020 · BUSPIRONE 10MG TAB · قرص بوسپیرون ۱۰ میلیگرم
- 01888 · BUSPIRONE 5MG TAB · قرص بوسپیرون ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Buspirone · Patient instructions — breaking the 15 mg tabletFDA Buspirone · Dosage and AdministrationFDA Buspirone · ContraindicationsFDA Buspirone · Precautions/Warnings – PregnancyFDA Buspirone · Nursing MothersFDA Buspirone · Pediatric UseFDA Buspirone · Precautions/Warnings – Geriatric UseFDA Buspirone · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1238/Buspirone
- Clinical review⚠ Unverified